Who is sponsoring NCT06715189?

NCT06715189 is sponsored by Sohag University.

What drugs are being tested in NCT06715189?

Interventions in NCT06715189: serum Adiponectine and Resistin, fibroscan.

What condition does NCT06715189 study?

NCT06715189 studies Hepatic Fibrosis.

Is NCT06715189 still recruiting?

NCT06715189 is currently not yet recruiting. Last updated 4 December 2024.

Last reviewed 2024-12-04 · How we verify

NCT06715189

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic Fibrosis in MASlD With type2 Diabetes Mellitus

Not yet recruiting Last updated 4 December 2024

What this trial tests

trial testing serum Adiponectine and Resistin in Hepatic Fibrosis in 80 participants. Not yet recruiting.

Timeline

1 December 2024

Primary endpoint
1 December 2025

30 December 2025

Quick facts

Lead sponsor	Sohag University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	80
Start date	1 December 2024
Primary completion	1 December 2025
Estimated completion	30 December 2025

Drugs / interventions tested

serum Adiponectine and Resistin
fibroscan

Conditions studied

Hepatic Fibrosis — all drugs for Hepatic Fibrosis →

Sponsor

Sohag University

Who can join

Adults 30 to 65, any sex, with Hepatic Fibrosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Metabolic dysfunction asociated steatotic liver disease prevalence is 25%world wide diabetic patients have a risk for MASLD then have hepatic fibrosis so we study correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic fibrosis In Metabolic dysfunction asociated steatotic liver disease in patients with type2 Diabetes Mellitus

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06715189 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 4 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06715189.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing